The Influence of Long-Acting Somatostatin Analogs on (68)Ga-DOTATATE Uptake in Patients With Neuroendocrine Tumors

A high SUV(max) tumor-to-liver ratio (TLR) of (68)Ga-DOTATATE can be used to select patients with neuroendocrine tumors (NETs) for peptide receptor radionuclide therapy (PRRT). In addition, an SUV(max) TLR ≥ 8.1 is associated with increased progression-free survival in NET patients treated with soma...

Descripción completa

Detalles Bibliográficos
Autores principales: Chahid, Youssef, Hashimi, Khaled, van de Garde, Ewoudt M.W., Klümpen, Heinz-Josef, Hendrikse, N. Harry, Booij, Jan, Verberne, Hein J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417218/
https://www.ncbi.nlm.nih.gov/pubmed/37486312
http://dx.doi.org/10.1097/RLU.0000000000004776

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417218/
https://www.ncbi.nlm.nih.gov/pubmed/37486312
http://dx.doi.org/10.1097/RLU.0000000000004776

Ejemplares similares